Stifel Financial’s CONMED CNMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.77M | Buy |
50,122
+9,268
| +23% | +$377K | ﹤0.01% | 2054 |
|
|
2025
Q4 | $1.66M | Buy |
40,854
+1,125
| +3% | +$48.9K | ﹤0.01% | 2062 |
|
|
2025
Q3 | $1.87M | Sell |
39,729
-4,648
| -10% | -$241K | ﹤0.01% | 1966 |
|
|
2025
Q2 | $2.31M | Buy |
44,377
+3,563
| +9% | +$196K | ﹤0.01% | 1743 |
|
|
2025
Q1 | $2.46M | Buy |
40,814
+7,671
| +23% | +$494K | ﹤0.01% | 1616 |
|
|
2024
Q4 | $2.27M | Buy |
33,143
+2,468
| +8% | +$172K | ﹤0.01% | 1687 |
|
|
2024
Q3 | $2.21M | Buy |
30,675
+3,712
| +14% | +$262K | ﹤0.01% | 1708 |
|
|
2024
Q2 | $1.87M | Buy |
26,963
+6,460
| +32% | +$471K | ﹤0.01% | 1768 |
|
|
2024
Q1 | $1.64M | Buy |
20,503
+3,156
| +18% | +$281K | ﹤0.01% | 1869 |
|
|
2023
Q4 | $1.9M | Buy |
17,347
+1,532
| +10% | +$158K | ﹤0.01% | 1700 |
|
|
2023
Q3 | $1.6M | Buy |
15,815
+1,517
| +11% | +$174K | ﹤0.01% | 1742 |
|
|
2023
Q2 | $1.94M | Sell |
14,298
-2,100
| -13% | -$256K | ﹤0.01% | 1647 |
|
|
2023
Q1 | $1.7M | Buy |
16,398
+3,760
| +30% | +$364K | ﹤0.01% | 1684 |
|
|
2022
Q4 | $1.12M | Buy |
12,638
+513
| +4% | +$42.6K | ﹤0.01% | 1910 |
|
|
2022
Q3 | $973K | Buy |
12,125
+1,182
| +11% | +$112K | ﹤0.01% | 1986 |
|
|
2022
Q2 | $1.05M | Buy |
10,943
+1,997
| +22% | +$240K | ﹤0.01% | 1960 |
|
|
2022
Q1 | $1.33M | Buy |
8,946
+102
| +1% | +$14.2K | ﹤0.01% | 1914 |
|
|
2021
Q4 | $1.25M | Buy |
8,844
+1,079
| +14% | +$153K | ﹤0.01% | 1949 |
|
|
2021
Q3 | $1.02M | Buy |
7,765
+2,022
| +35% | +$265K | ﹤0.01% | 2096 |
|
|
2021
Q2 | $790K | Buy |
5,743
+1,778
| +45% | +$243K | ﹤0.01% | 2271 |
|
|
2021
Q1 | $518K | Buy |
3,965
+934
| +31% | +$112K | ﹤0.01% | 2464 |
|
|
2020
Q4 | $339K | Buy |
3,031
+121
| +4% | +$11.5K | ﹤0.01% | 2537 |
|
|
2020
Q3 | $229K | Buy |
+2,910
| New | +$237K | ﹤0.01% | 2548 |
|
|
2020
Q1 | – | Sell |
-1,868
| Closed | -$207K | – | 2860 |
|
|
2019
Q4 | $207K | Buy |
+1,868
| New | +$199K | ﹤0.01% | 2746 |
|
|
2016
Q4 | – | Sell |
-53,000
| Closed | -$2.12M | – | 2474 |
|
|
2016
Q3 | $2.12M | Sell |
53,000
-1,600
| -3% | -$67.9K | 0.01% | 962 |
|
|
2016
Q2 | $2.61M | Sell |
54,600
-4,000
| -7% | -$169K | 0.01% | 886 |
|
|
2016
Q1 | $2.46M | Sell |
58,600
-4,800
| -8% | -$188K | 0.01% | 836 |
|
|
2015
Q4 | $2.79M | Sell |
63,400
-1,400
| -2% | -$60.8K | 0.01% | 814 |
|
|
2015
Q3 | $3.09M | Buy |
64,800
+700
| +1% | +$38.4K | 0.02% | 732 |
|
|
2015
Q2 | $3.73M | Buy |
64,100
+3,600
| +6% | +$194K | 0.02% | 695 |
|
|
2015
Q1 | $3.05M | Buy |
60,500
+4,800
| +9% | +$235K | 0.02% | 770 |
|
|
2014
Q4 | $2.5M | Buy |
55,700
+4,400
| +9% | +$184K | 0.01% | 811 |
|
|
2014
Q3 | $1.89M | Sell |
51,300
-600
| -1% | -$23.8K | 0.02% | 785 |
|
|
2014
Q2 | $2.29M | Sell |
51,900
-1,000
| -2% | -$45.3K | 0.02% | 728 |
|
|
2014
Q1 | $2.3M | Buy |
+52,900
| New | +$2.36M | 0.02% | 702 |
|
Other funds holding CNMD
VPM
VCM
CB
Stifel Financial's CNMD Position: Q1 2026 in Review
Stifel Financial increased its CONMED (CNMD) stake by 23% in Q1 2026, buying an estimated $377K and bringing the position to 50,122 shares worth $1.77M. The position accounts for ﹤0.01% of the portfolio, ranked #2054.
Stifel Financial first reported a position in CNMD in Q1 2014 and has held it in 35 quarters since. The position peaked at $3.73M in Q2 2015. 236 funds tracked by Wall St. Rank hold CNMD as of Q1 2026.
- Stifel Financial held 50,122 shares of CONMED worth $1.77M as of Q1 2026.
- Stifel Financial bought 9,268 CONMED shares in Q1 2026, an estimated $377K.
- CONMED made up ﹤0.01% of Stifel Financial's portfolio in Q1 2026, its #2054 holding.
- Stifel Financial first reported a position in CONMED in Q1 2014 and has held it in 35 quarters since.
- Stifel Financial's CONMED position peaked at $3.73M in Q2 2015.
- 236 funds tracked by Wall St. Rank held CONMED as of Q1 2026.
Based on Stifel Financial's 13F filing for Q1 2026, filed 12 May 2026.